Can a 4-Week virtual program help people stop drinking? new study tests remote breathalyzer monitoring

NCT ID NCT05722483

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a 4-week virtual intensive outpatient program for 63 people with moderate to severe alcohol use disorder. The program included group therapy, individual therapy, medication management, and multiple daily breathalyzer checks using facial recognition. The goal was to see if people would stay in the program and find it satisfactory, with a target retention rate of at least 50%.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Virtual intensive outpatient program (cognitive behavioral therapy, DBT skills, health and wellness groups, individual therapy, medication management, and remote breathalyzer monitoring)
What this could lead to
If successful, this could show that a fully virtual program can help people with alcohol use disorder stay abstinent and engaged in treatment, offering a more accessible option than residential care.
What could go wrong
This is a small, single-arm pilot study with no comparison group, so results may not prove effectiveness. The program is intensive and may not suit everyone, and long-term outcomes beyond the 4-week period are not measured.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre for Addiction and Mental Health

    Toronto, Ontario, M6J 1H4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.